Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001601485-24-000093
Filing Date
2024-11-25
Accepted
2024-11-25 07:34:21
Documents
1
Period of Report
2024-11-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1732538054.html 4  
1 FORM 4 wk-form4_1732538054.xml 4 4064
  Complete submission text file 0001601485-24-000093.txt   5461
Mailing Address
Business Address
RUFFOLO ROBERT R (Reporting) CIK: 0001187308 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39990 | Film No.: 241491953

Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Issuer) CIK: 0001601485 (see all company filings)

EIN.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)